← Leaderboards
Peter Tyler
Texas A&M Agrilife Research
$1,718,251
Attributed
$5,154,754
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,154,754 · 1
By mechanism
R01$5,154,754 · 1
Top collaborators
- Thomas Meek5 shared
- Vern L. Schramm5 shared
Most similar at Texas A&M Agrilife Research
Same institution · by research overlap
- Thomas Meek$2,544,314
Others in their field
Other Emerging Leaders on “Adopted”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,235,661
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Abraham Aizer Brody · New York University School Of Medicine$24,513,574
Research focus
AdoptedAfricanAfrican TrypanosomiasisAnabolismAnalogAnimal ModelAotus PrimateBaseBindingBioavailableCatalysisCell Culture TechniquesCellsCentral AmericaChagas DiseaseChemical SynthesisChemistryComparativeComplexComputational ChemistryCrystallizationCultured CellsDesignActive Sites
Grant awards (5)
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,003,662
R01 · FY2021 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,020,767
R01 · FY2020 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,014,009
R01 · FY2019 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,032,586
R01 · FY2018 · AI
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE$1,083,730
R01 · FY2017 · AI